(Q33724588)

28 July 2017

title

Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent (English)

1 reference

28 July 2017

Alessandro Subissi

1

1 reference

28 July 2017

Daniela Monti

series ordinal

2

1 reference

28 July 2017

Giuseppe Togni

series ordinal

3

1 reference

28 July 2017

Federico Mailland

series ordinal

4

1 reference

28 July 2017

publication date

1 November 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

70

1 reference

28 July 2017

issue

16

1 reference

28 July 2017

page(s)

2133-2152

1 reference

In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer

28 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11538110-000000000-00000

Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis

21 January 2018

1 reference

12 December 2020

Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.

1 reference

12 December 2020

Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris

1 reference

12 December 2020

Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections

1 reference

12 December 2020

Ciclopirox gel for seborrheic dermatitis of the scalp

1 reference

12 December 2020

The use of topical therapies to treat onychomycosis

1 reference

12 December 2020

Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes

1 reference

12 December 2020

Mycotic vulvovaginitis and topical cyclopiroxolamine

1 reference

12 December 2020

Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%

1 reference

12 December 2020

Ciclopirox gel in the treatment of patients with interdigital tinea pedis

1 reference

12 December 2020

Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme

1 reference

12 December 2020

Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.

1 reference

12 December 2020

In vitro antimycotic activity and nail permeation models of a piroctone olamine (octopirox) containing transungual water soluble technology

1 reference

12 December 2020

Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis

1 reference

12 December 2020

The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro

1 reference

12 December 2020

Ciclopirox olamine directly scavenges hydroxyl radical

1 reference

12 December 2020

Ciclopiroxolamine in the topical treatment of vaginal mycoses

1 reference

12 December 2020

Pharmacokinetics of ciclopirox olamine after vaginal application to rabbits and patients

1 reference

12 December 2020

Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial

1 reference

12 December 2020

Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors

1 reference

12 December 2020

A comparative double blind trial with vaginal creams of cyclopyroxolamine and miconazole in vulvovaginal candidosis (author's transl)

1 reference

12 December 2020

Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies

1 reference

12 December 2020

Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis

1 reference

12 December 2020

Toenail onychomycosis: current and future treatment options

1 reference

12 December 2020

Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study

1 reference

12 December 2020

Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.

1 reference

12 December 2020

Onychomycosis by molds. Report of 78 cases

1 reference

12 December 2020

[Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)]

1 reference

12 December 2020

[Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)]

1 reference

12 December 2020

Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial

1 reference

12 December 2020

[The susceptibility of Aspergillus and Penicillium to recent antimycotics]

1 reference

12 December 2020

Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis

1 reference

12 December 2020

Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans

1 reference

12 December 2020

Ciclopirox olamine: A hydroxypyridone antifungal agent

1 reference

12 December 2020

Effects of subinhibitory concentrations of ciclopirox on the adherence of Candida albicans to human buccal and vaginal epithelial cells

1 reference

12 December 2020

Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.

1 reference

12 December 2020

[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis]

1 reference

12 December 2020

Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect

1 reference

12 December 2020

A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes

1 reference

12 December 2020

In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains

1 reference

12 December 2020

Treatment of therapy refractory verrucae vulgares with a ciclopirox-containing lacquer

1 reference

12 December 2020

Aspartyl proteinases of Candida albicans and their role in pathogenicity

1 reference

12 December 2020

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis

1 reference

12 December 2020

Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum

1 reference

12 December 2020

[Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)]

1 reference

12 December 2020

[Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration]

1 reference

12 December 2020

[Pityriasis versicolor and the yeasts of genus Malassezia]

1 reference

12 December 2020

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

1 reference

12 December 2020

Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria

1 reference

12 December 2020

An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.

1 reference

12 December 2020

[Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream]

1 reference

12 December 2020

Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial

1 reference

12 December 2020

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis

1 reference

12 December 2020

Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison

1 reference

12 December 2020

In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.

1 reference

12 December 2020

Antifungal agents: mode of action in yeast cells

1 reference

12 December 2020

Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective.

1 reference

12 December 2020

1 reference

12 December 2020

Effect of fenticonazole spray in cutaneous mycosis: a double-blind clinical trial versus cyclopyroxolamine spray

1 reference

12 December 2020

Ciclopirox (Loprox) gel for superficial fungal infections.

1 reference

12 December 2020

Anti-inflammatory activity of antifungal preparations

1 reference

12 December 2020

Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.

1 reference

12 December 2020

Therapy problems in chronic recurrent vaginal mycosis

1 reference

12 December 2020

Piperidones with activity against Plasmodium falciparum

1 reference

12 December 2020

The antitumor activity of the fungicide ciclopirox

1 reference

12 December 2020

Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates

1 reference

12 December 2020

Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage

1 reference

12 December 2020

A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic derm

1 reference

12 December 2020

[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy]

1 reference

12 December 2020

The treatment of acute mycotic colpitis with ciclopiroxolamine (Dafnegin-CSC) in pregnant patients in the 10th lunar month

1 reference

12 December 2020

A clinical study of cyclopyroxolamine versus clotrimazole in the treatment of mycotic vulvovaginitis

1 reference

12 December 2020

Mode of Action of 6-Cyclohexyl-l-hydroxy-4-methyl-2(1H)-pyridone Ethanolamine Salt (Hoe 296)

1 reference

12 December 2020

Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

1 reference

12 December 2020

[The treatment of acute mycotic colpitis with ciclopiroxolamine in patients using oral contraceptives]

1 reference

12 December 2020

Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology

1 reference

12 December 2020

Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis

1 reference

12 December 2020

[In vitro antifungal spectrum of ciclopiroxolamine]

1 reference

12 December 2020

Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans

1 reference

12 December 2020

Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases

1 reference

12 December 2020

Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties

1 reference

12 December 2020

Topical application of a 0.1% ciclopiroxolamine solution for the treatment of pityriasis versicolor

1 reference

12 December 2020

Ciclopirox for the treatment of superficial fungal infections: a review

1 reference

12 December 2020

[Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)]

1 reference

12 December 2020

HOE 296, a new antimycotic compound with a broad antimicrobial spectrum. Laboratory results

1 reference

12 December 2020

[Non-European open clinical studies on the efficacy and tolerance of ciclopiroxolamine in dermatomycoses (author's transl)]

1 reference

12 December 2020

Evaluation of a polymerase chain reaction-restriction fragment length polymorphism assay for dermatophyte and nondermatophyte identification in onychomycosis.

1 reference

12 December 2020

In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity

1 reference

12 December 2020

Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses

1 reference

12 December 2020

In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method

1 reference

12 December 2020

Inhibitory or scavenging action of ketoconazole and ciclopiroxolamine against reactive oxygen species released by primed inflammatory cells

1 reference

12 December 2020

Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis

1 reference

12 December 2020

Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study

1 reference

12 December 2020

Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo

1 reference

12 December 2020

Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans

1 reference

12 December 2020

10.2165/11538110-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1051337515

0 references

1 reference